Abstract
Alzheimer’s disease (AD) and cerebral amyloid angiopathy (CAA) are neurodegenerative diseases that are pathologically defined by accumulations of amyloid beta (Aβ) in the brain parenchyma and vascular walls, respectively. CAA comorbidity occurs in more than half of advanced AD cases. Aβ can activate complement, an enzymatic cascade that terminates in a cytolytic pore called membrane attack complex (MAC). Protectin (CD59) is a GPI-anchored glycoprotein that physically interrupts formation of MAC. At autopsy, individuals with AD and CAA have high levels of MAC and normal to low levels of CD59 in the tunica media of affected blood vessels. We proposed the introduction of exogenous CD59 gene expression via a plasmid (pDNA) to rescue cerebrovascular smooth muscle cells (cvSMC) from lysis by MAC. Chitosan (Cs) is a linear glucosamine polysaccharide that is well described in a variety of nano- and micro-carrier payload delivery applications and frequently considered biologically inert. In this investigation we examined the stability of chitosan microparticles (CsM) under physiologic conditions and describe the response of primary human cvSMC to CsM and pDNA-loaded CsM (pCsM) as quantified by flow cytometry. We also explored the impact of chitosan polymers, the building blocks of CsM, on CD59 expression in cvSMC. We found that CsM are not stable under standard cell culture conditions while in cell culture media. CsM effectively delivered plasmid into cvSMC, as evidenced by high CD59 mRNA expression levels 24 h after transfection. However, this effect appeared to be lost in translation and no increase in CD59 surface expression was seen after treatment with pCsM. Surprisingly, Cs alone induced robust and persistent increases CD59 in cvSMC surface expression. These finds challenge assumption that Cs is inert and encourage the use of chitosan-only controls in future transfection experiments.
LLU Discipline
Microbiology and Molecular Genetics
Department
Microbiology
School
School of Medicine
First Advisor
Wolff Kirsch
Second Advisor
Penelope Duerksen-Hughes
Third Advisor
Samuel Hudson
Fourth Advisor
William Pearce
Fifth Advisor
Salvador Soriano
Degree Name
Doctor of Philosophy (PhD)
Degree Level
Ph.D.
Year Degree Awarded
2019
Date (Title Page)
9-2019
Language
English
Library of Congress/MESH Subject Headings
Neurodegenerative Diseases; Chitosan; CD59 Antigens; Complement Membrane Attack Complex
Type
Dissertation
Page Count
xiv, 114 p.
Digital Format
Digital Publisher
Loma Linda University Libraries
Copyright
Author
Usage Rights
This title appears here courtesy of the author, who has granted Loma Linda University a limited, non-exclusive right to make this publication available to the public. The author retains all other copyrights.
Recommended Citation
Cupino, Tanya Larissa, "Chitosan as an Immune Modulator: Therapeutic Potential in Cerebral Amyloidopathies" (2019). Loma Linda University Electronic Theses, Dissertations & Projects. 1918.
https://scholarsrepository.llu.edu/etd/1918
Collection
Loma Linda University Electronic Theses and Dissertations
Collection Website
http://scholarsrepository.llu.edu/etd/
Repository
Loma Linda University. Del E. Webb Memorial Library. University Archives